Novel small synthetic HIV-1 V3 crown variants: CCR5 targeting ligands

The CC chemokine receptor 5 (CCR5) antagonism represents a promising pharmacological strategy for therapeutic intervention as it plays a significant role in reducing the severity and progression of a wide range of pathological conditions. Here we designed and generated peptide ligands targeting the...

Descripción completa

Detalles Bibliográficos
Autores principales: Anitha, Anju Krishnan, Narayanan, Pratibha, Ajayakumar, Neethu, Sivakumar, Krishnankutty Chandrika, Kumar, Kesavakurup Santhosh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Regular Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445593/
https://www.ncbi.nlm.nih.gov/pubmed/35708645
http://dx.doi.org/10.1093/jb/mvac052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445593/
https://www.ncbi.nlm.nih.gov/pubmed/35708645
http://dx.doi.org/10.1093/jb/mvac052

Ejemplares similares